Welcome to Creative Biolabs' CIK Genetic Engineering and Modification Service. As a pioneer in the field of cellular therapies, we offer specialized services to genetically modify Cytokine-Induced Killer (CIK) cells to enhance their anti-tumor efficacy. With the rapid advancements in genetic engineering technologies, the potential for creating more potent and targeted immune cells has never been greater. Our service is designed to empower researchers by developing customized CIK cell therapies tailored to address the complexities of cancer treatment.
Cytokine-induced Killer cells are a robust population of immune cells that can recognize and eliminate cancer cells. These cells can be enhanced through genetic modification to improve their functionality, persistence, and ability to target specific tumor types. Techniques such as transduction with viral vectors, and gene expression modification can significantly augment the therapeutic potential of CIK cells. Our CIK Genetic Engineering and Modification Service aims to leverage these technologies to create superior cell products that can be used in preclinical studies against various malignancies.
Our CIK Genetic Engineering and Modification Service is meticulously designed to ensure that you receive high-quality, genetically modified CIK cells that meet your research requirements. The process includes the following key steps:
Genetic Modification: We utilize advanced genetic engineering techniques to modify the CIK cells, which may include:
Gene Editing: For precise gene knockout or modifications to enhance cell functionality or resistance to immunosuppression.
Viral Transduction: Employing lentiviral or retroviral vectors to introduce genes encoding chimeric antigen receptors (CARs) or other effector molecules to enhance tumor targeting and killing capabilities.
Quality Control and Characterization: After the genetic modification process, we perform rigorous quality control assessments to evaluate the efficiency of modification, including:
Flow Cytometric Analysis: This allows us to assess surface marker expression and confirm successful transduction or gene editing.
Functional Assays: We evaluate the cytotoxic activity of genetically modified CIK cells against target tumor cells to ensure their efficacy.
At Creative Biolabs, we are committed to enhancing the capabilities of CIK cells through our Genetic Engineering and Modification Service. Our expert team, advanced technologies, and customized approach ensure that you receive high-quality, effective cell products tailored to your specific needs. Contact us today to learn how we can support your research and help you harness the full potential of genetically modified CIK cells in cancer therapy!
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION